Prime Medicine, Inc. revenue for the last year amounted to 2.98 M USD, the most of which — 2.98 M USD — came from its highest performing source at the moment, Genetic Therapies, the year earlier bringing 5.21 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Prime Medicine, Inc. 2.98 M USD, and the year before that — 5.21 M USD.